Safety Study of New Drug HSK56630 in Healthy People
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old
- Have a normal weight range (BMI 18.0–30.0) and weigh at least 45–50 kg depending on sex
- Be in generally good health with no serious medical conditions (heart, lung, kidney, liver, immune, or nervous system problems)
- Pass basic health screening tests (blood work, urine, chest X-ray, abdominal ultrasound, and heart rhythm test)
- Agree not to take most other medicines, supplements, or herbal products for at least 7–14 days before the study starts
- Be willing to stay at the research facility for the study period and attend all required visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests an experimental drug called HXN6005 in healthy adults to see how safe it is and how the body handles it. It's looking for volunteers who are generally healthy and meet basic age and weight requirements.
This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.